Privia Health Group, Inc. current report, 16 August 2021

Privia Health Group, Inc. Form 8-K Summary

Business Context and Reporting Period

Privia Health Group, Inc. filed a Current Report on Form 8-K dated August 16, 2021. The company is a Delaware corporation headquartered in Arlington, Virginia, and its common stock trades on The Nasdaq Global Select Market under the symbol PRVA.

The filing was submitted under Item 7.01, Regulation FD Disclosure, to furnish materials for meetings with institutional investors and analysts. The attached Exhibit 99.1 is identified as the “Privia Health Group, Inc. Investor Presentation Slides - August 2021.” The presentation itself is not included in the provided filing text.

Financial Metrics and Capital Position

The provided filing text does not include revenue, profit or loss, cash flow, margins, debt, liquidity, operating statistics, or other financial metrics. No financial statements are furnished with this filing.

Material Changes Versus the Prior Comparable Period

The filing does not report a comparison with a prior period or disclose specific changes in financial or operating performance.

Guidance, Outlook, Risks, and Unusual Items

The filing text does not provide specific guidance, outlook targets, management commentary, risk factors, contingencies, or unusual financial items. The company states that the furnished information may be amended or updated through a subsequent Form 8-K, later filing, or other means.

The company expressly disclaims an obligation to publicly update forward-looking statements or changes in expectations, events, conditions, or circumstances on which such statements are based.

The information is furnished under Item 7.01 and, including the exhibit, is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.

Important Facts to Verify

  • Obtain and review Exhibit 99.1, the August 2021 investor presentation, for the underlying business, financial, and outlook information.
  • Verify whether subsequent filings amended or updated the investor presentation or related forward-looking statements.
  • Review the company’s periodic filings for financial statements, liquidity, debt, operating metrics, and comparable-period trends.